| Trial ID: | L6926 |
| Source ID: | NCT00682097
|
| Associated Drug: |
Ro4998452
|
| Title: |
A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: RO4998452|DRUG: placebo
|
| Outcome Measures: |
Primary: AEs, laboratory parameters, vital signs., Throughout study|AUC0-24h, Cmax, Days 1 and 14 | Secondary: Parameters of glucose metabolism, Throughout study
|
| Sponsor/Collaborators: |
Sponsor: Hoffmann-La Roche
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
55
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-05
|
| Completion Date: |
2009-03
|
| Results First Posted: |
|
| Last Update Posted: |
2016-11-02
|
| Locations: |
Chula Vista, California, 91911, United States|San Antonio, Texas, 78229, United States|Neuss, 41460, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00682097
|
